These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
124 related articles for article (PubMed ID: 38101299)
1. Analysis of multiple programmed cell death-related prognostic genes and functional validations of necroptosis-associated genes in oesophageal squamous cell carcinoma. Cao K; Zhu J; Lu M; Zhang J; Yang Y; Ling X; Zhang L; Qi C; Wei S; Zhang Y; Ma J EBioMedicine; 2024 Jan; 99():104920. PubMed ID: 38101299 [TBL] [Abstract][Full Text] [Related]
2. Enhancer demethylation-regulated gene score identified molecular subtypes, inspiring immunotherapy or CDK4/6 inhibitor therapy in oesophageal squamous cell carcinoma. Gao W; Liu S; Wu Y; Wei W; Yang Q; Li W; Chen H; Luo A; Wang Y; Liu Z EBioMedicine; 2024 Jul; 105():105177. PubMed ID: 38924839 [TBL] [Abstract][Full Text] [Related]
3. Overexpression of Cullin4A correlates with a poor prognosis and tumor progression in esophageal squamous cell carcinoma. Nakade H; Migita K; Matsumoto S; Wakatsuki K; Kunishige T; Miyao S; Sho M Int J Clin Oncol; 2020 Mar; 25(3):446-455. PubMed ID: 31535245 [TBL] [Abstract][Full Text] [Related]
4. Screening of genes related to programmed cell death in esophageal squamous cell carcinoma and construction of prognostic model based on transcriptome analysis. Chen M; Qi Y; Zhang S; Du Y; Cheng H; Gao S Expert Rev Anticancer Ther; 2024 Sep; 24(9):905-915. PubMed ID: 38975629 [TBL] [Abstract][Full Text] [Related]
5. A fibroblast-associated signature predicts prognosis and immunotherapy in esophageal squamous cell cancer. Ren Q; Zhang P; Zhang X; Feng Y; Li L; Lin H; Yu Y Front Immunol; 2023; 14():1199040. PubMed ID: 37313409 [TBL] [Abstract][Full Text] [Related]
6. EIF3H promotes aggressiveness of esophageal squamous cell carcinoma by modulating Snail stability. Guo X; Zhu R; Luo A; Zhou H; Ding F; Yang H; Liu Z J Exp Clin Cancer Res; 2020 Aug; 39(1):175. PubMed ID: 32867821 [TBL] [Abstract][Full Text] [Related]
7. Construction of a novel pyrotosis-related prognostic model of esophageal square cell carcinoma and determination of the anti-tumor effect of WFDC12. Zhuang Y; Wang L; Ji C; Sun Y; Shao F Funct Integr Genomics; 2023 May; 23(2):177. PubMed ID: 37225895 [TBL] [Abstract][Full Text] [Related]
8. Keratin 17 activates AKT signalling and induces epithelial-mesenchymal transition in oesophageal squamous cell carcinoma. Liu Z; Yu S; Ye S; Shen Z; Gao L; Han Z; Zhang P; Luo F; Chen S; Kang M J Proteomics; 2020 Jan; 211():103557. PubMed ID: 31669361 [TBL] [Abstract][Full Text] [Related]
9. Innovative prognostic modeling in ESCC: leveraging scRNA-seq and bulk-RNA for dendritic cell heterogeneity analysis. Shi M; Zhang H; Ma L; Wang X; Sun D; Feng Z Front Immunol; 2024; 15():1352454. PubMed ID: 38515748 [TBL] [Abstract][Full Text] [Related]
10. Regulation of Hippo/YAP signaling and Esophageal Squamous Carcinoma progression by an E3 ubiquitin ligase PARK2. Zhou X; Li Y; Wang W; Wang S; Hou J; Zhang A; Lv B; Gao C; Yan Z; Pang D; Lu K; Ahmad NH; Wang L; Zhu J; Zhang L; Zhuang T; Li X Theranostics; 2020; 10(21):9443-9457. PubMed ID: 32863938 [No Abstract] [Full Text] [Related]
11. GINS4 might be a novel prognostic immune-related biomarker of not only esophageal squamous cell carcinoma and other cancers. Jin D; Yuan L; Li F; Wang S; Mao Y BMC Med Genomics; 2022 Apr; 15(1):75. PubMed ID: 35365175 [TBL] [Abstract][Full Text] [Related]
12. Integrated analysis of genomic and transcriptomic profiles identified a prognostic immunohistochemistry panel for esophageal squamous cell cancer. Yu Y; Li Z; Huang C; Fang H; Zhao F; Zhou Y; Pan X; Li Q; Zhuang Y; Chen L; Xu J; Wang W Cancer Med; 2020 Jan; 9(2):575-585. PubMed ID: 31793228 [TBL] [Abstract][Full Text] [Related]
13. Genome-wide copy number variation analysis identified ANO1 as a novel oncogene and prognostic biomarker in esophageal squamous cell cancer. Yu Y; Cao J; Wu W; Zhu Q; Tang Y; Zhu C; Dai J; Li Z; Wang J; Xue L; Zhen F; Liu J; Huang C; Zhao F; Zhou Y; Wen W; Pan X; Wei H; Zhu Y; He Y; Que J; Wang W; Luo J; Xu J; Chen L Carcinogenesis; 2019 Oct; 40(10):1198-1208. PubMed ID: 31050728 [TBL] [Abstract][Full Text] [Related]
14. Molecular analysis of Chinese oesophageal squamous cell carcinoma identifies novel subtypes associated with distinct clinical outcomes. Liu M; An H; Zhang Y; Sun W; Cheng S; Wang R; Wang X; Feng L EBioMedicine; 2020 Jul; 57():102831. PubMed ID: 32580137 [TBL] [Abstract][Full Text] [Related]
15. S1PR1 promotes proliferation and inhibits apoptosis of esophageal squamous cell carcinoma through activating STAT3 pathway. Liu Y; Zhi Y; Song H; Zong M; Yi J; Mao G; Chen L; Huang G J Exp Clin Cancer Res; 2019 Aug; 38(1):369. PubMed ID: 31438989 [TBL] [Abstract][Full Text] [Related]
16. High expression of Collagen Triple Helix Repeat Containing 1 (CTHRC1) facilitates progression of oesophageal squamous cell carcinoma through MAPK/MEK/ERK/FRA-1 activation. Wang C; Li Z; Shao F; Yang X; Feng X; Shi S; Gao Y; He J J Exp Clin Cancer Res; 2017 Jun; 36(1):84. PubMed ID: 28645305 [TBL] [Abstract][Full Text] [Related]
17. Evodiamine inhibits ESCC by inducing M-phase cell-cycle arrest via CUL4A/p53/p21 axis and activating noxa-dependent intrinsic and DR4-dependent extrinsic apoptosis. Zhang L; Li L; Chen X; Yuan S; Xu T; Zhao W; Li M; Wang F; Hoffman RM; Jia L Phytomedicine; 2023 Jan; 108():154493. PubMed ID: 36265256 [TBL] [Abstract][Full Text] [Related]
18. A risk prognostic model for patients with esophageal squamous cell carcinoma basing on cuproptosis and ferroptosis. Li J; Liu J; Li J; Feng A; Nie Y; Yang Z; Zhang W J Cancer Res Clin Oncol; 2023 Oct; 149(13):11647-11659. PubMed ID: 37405477 [TBL] [Abstract][Full Text] [Related]
19. A PLK1 kinase inhibitor enhances the chemosensitivity of cisplatin by inducing pyroptosis in oesophageal squamous cell carcinoma. Wu M; Wang Y; Yang D; Gong Y; Rao F; Liu R; Danna Y; Li J; Fan J; Chen J; Zhang W; Zhan Q EBioMedicine; 2019 Mar; 41():244-255. PubMed ID: 30876762 [TBL] [Abstract][Full Text] [Related]